| Bioactivity | SCR-1481B1 free base, also known as Metatinib free base, is a small molecule receptor kinase inhibitor that targets both c-MET and vascular endothelial growth factor receptor 2 (VEGFR2)[1]. |
| CAS | 1174161-69-3 |
| Formula | C24H18ClF2N4O7P |
| Molar Mass | 578.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cheng K, et al. Safety, Efficacy, and Pharmacokinetics of Metatinib Tromethamine Tablet in Patients with Advanced Refractory Solid Tumors: A Phase I Clinical Trial. Oncologist. 2021 Aug;26(8):649-e1313. |
SCR-1481B1 free base
CAS: 1174161-69-3 F: C24H18ClF2N4O7P W: 578.85
SCR-1481B1 free base, also known as Metatinib free base, is a small molecule receptor kinase inhibitor that targets both
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.